Co-design of the ‘OurFutures Vaping’ programme: a school-based eHealth intervention to prevent e-cigarette use
Health Promotion International · 2025
DOI: 10.1093/heapro/daaf085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Promotion International, 2025. Verfasst von Lauren A Gardner und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Vaping, Telemedicine, Electronic Nicotine Delivery Systems, School Health Services. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Paul Ramsay Foundation.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Effective preventive interventions are urgently needed to address e-cigarette use (‘vaping’) and related harms among young people. There is a strong evidence base supporting the delivery of substance use preventive interventions in the school setting, and eHealth interventions can overcome common implementation barriers. However, there is a dearth of effective school-based e-cigarette preventive interventions available. This study summarizes the co-design and user testing of the ‘OurFutures Vaping’ programme, a universal school-based eHealth preventive intervention targeting e-cigarette use. The intervention is based on the effective ‘OurFutures’ prevention model, which adopts a harm minimization and comprehensive social influence approach to prevention and delivers content via interactive cartoons and supporting resources. Beginning in March 2022, the development process involved four iterative stages: (i) scoping of the literature; (ii) consultations with young people (n = 34; 14–16 years) to understand attitudes and perceptions about e-cigarettes/tobacco cigarettes and develop cartoon character profiles and storylines; (iii) content and web development; and (iv) user testing and refinement with students (n = 37; 13–14 years) and teachers (n = 13). Key areas for improvement included lesson length, believability and relevance of some storylines, incorporating resources on e-cigarette addiction and cessation, and tweaking illustrations. Refinements were made and the final intervention comprised four 40 min online cartoon lessons with accompanying teacher-facilitated activities, factsheets, and resources. The ‘OurFutures Vaping’ programme is the first school-based e-cigarette preventive intervention in Australia to be developed via iterative co-design, grounded in evidence, and to undergo rigorous evaluation (cluster randomized controlled trial, 2023–26), holding the potential to make significant health and economic impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia.
- National Drug Research Institute, Curtin University, Perth, Australia.
ORCID-Profile: Lauren A Gardner, Lyra Egan
Förderung
- Paul Ramsay Foundation
Zitieren
APA
Gardner, L. A., Rowe, A. L., Stockings, E., Egan, L., Hawkins, A., Blackburn, K., Teesson, M., Champion, K. E., & Newton, N. C. (2025). Co-design of the ‘OurFutures Vaping’ programme: a school-based eHealth intervention to prevent e-cigarette use. Health Promotion International. https://doi.org/10.1093/heapro/daaf085
Vancouver
Gardner LA, Rowe AL, Stockings E, Egan L, Hawkins A, Blackburn K, et al. Co-design of the ‘OurFutures Vaping’ programme: a school-based eHealth intervention to prevent e-cigarette use. Health Promotion International. 2025. doi:10.1093/heapro/daaf085
BibTeX
@article{Gardner2025,
author = {Gardner, Lauren A and Rowe, Amy-Leigh and Stockings, Emily and Egan, Lyra and Hawkins, Annabelle and Blackburn, Kathleen and Teesson, Maree and Champion, Katrina E and Newton, Nicola C},
title = {Co-design of the ‘OurFutures Vaping’ programme: a school-based eHealth intervention to prevent e-cigarette use},
journal = {Health Promotion International},
year = {2025},
doi = {10.1093/heapro/daaf085}
}
EUVIMED